Dr. Spiegel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 elm st
Westfield, NJ 07090
Education & Training
- National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1977 - 1979
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1974 - 1977
- Perelman School of Medicine at the University of PennsylvaniaClass of 1975
- Yale UniversityB.A.
Certifications & Licensure
- NY State Medical License 1976 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 294 citationsAtaluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialCraig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S. Finkel, Kevin M. Flanigan
Lancet. 2017-09-23 - 249 citationsAtaluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W. Konstan, Kris De Boeck, Frank J. Accurso, Isabelle Sermet-Gaudelus
The Lancet. Respiratory Medicine. 2014-07-01 - 106 citationsPlasma lipid alterations in leukemia and lymphomaRobert J. Spiegel, Ernst J. Schaefer, Ian Magrath, Brenda K. Edwards
The American Journal of Medicine. 1982-05-01
Press Mentions
- Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of DirectorsAugust 4th, 2020
- What Will Happen to Cyclacel Pharmaceuticals, Inc. (CYCCP) Next? The Stock Formed a Several Months Descending Triangle PatternMarch 12th, 2019
- Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy CompanyDecember 8th, 2018
- Join now to see all
Professional Memberships
- Member
Industry Relationships
- Chief Medical Officer, Schering Plough1984 - 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: